Diagnostic Accuracy of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in the Evaluation of the Primary Tumor in Patients with Cholangiocarcinoma: A Meta-Analysis

The Clinical Value of Dual–Time Point 18F-FDG PET/CT for Differentiating Extrahepatic Cholangiocarcinoma From Benign Disease

(2013) Eun Kyoung Choi et al.   CLINICAL NUCLEAR MEDICINE

The Value of F-18 FDG PET in Patients With Primary Sclerosing Cholangitis and Cholangiocarcinoma Using Visual and Semiquantitative Analysis

(2011) Khaled Alkhawaldeh et al.   CLINICAL NUCLEAR MEDICINE

FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma

(2011) Anthony T. Ruys et al.   HPB

Prognostic value of18F-fluorodeoxyglucose positron emission tomography in patients with extrahepatic bile duct cancer

(2010) Koji Kitamura et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma

(2009) Seung Won Lee et al.   JOURNAL OF GASTROENTEROLOGY

Clinical Role of18F-FDG PET-CT in Suspected and Potentially Operable Cholangiocarcinoma: A Prospective Study Compared With Conventional Imaging

(2008) Ji Y. Kim et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Preoperative staging of biliary carcinoma using 18F-fluorodeoxyglucose PET: prospective comparison with PET+CT, MDCT and histopathology

(2008) Hiroyoshi Furukawa et al.   EUROPEAN RADIOLOGY

Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT

(2008) Jun Li et al.   JOURNAL OF SURGICAL ONCOLOGY

Usefulness of18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas

(2007) Chang Mo Moon et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

18F-fluorodeoxyglucose Positron Emission Tomography Influences Management Decisions in Patients with Biliary Cancer

(2007) Carlos U. Corvera et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS